aTyr Pharma Inc
Change company Symbol lookup
Select an option...
LIFE aTyr Pharma Inc
IBM International Business Machines Corp
APP Applovin Corp
NEXNF NEXE Innovations Inc
GRCL Gracell Biotechnologies Inc
NRG NRG Energy Inc
VNO Vornado Realty Trust
COTY Coty Inc
RPHM Reneo Pharmaceuticals Inc
TPX Tempur Sealy International Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.

Closing Price
$10.25
Day's Change
-2.23 (-17.87%)
Bid
--
Ask
--
B/A Size
--
Day's High
12.17
Day's Low
10.00
Volume
(Light)
Volume:
2,985,741

10-day average volume:
27,298,585
2,985,741

Latest Earnings (Q2 ending 06/2021)

Q2
-$0.64
Q2 Consensus estimate
-$0.51

Latest Earnings Estimate Range

Highest
estimate
-$0.31
Mean
estimate
-$0.51
Lowest
estimate
-$0.60

Quarterly Consensus Estimates and Ranges

LIFE's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.